Published in Blood Weekly, March 18th, 2010
"Dr. Pastan has been a leader in molecular biology for more than forty years and the AMA is pleased to honor him with this award," said AMA Board Chair Rebecca J. Patchin, M.D. "His seminal work in receptor biology has resulted in many important discoveries, including new treatments for a specific type of drug-resistant Leukemia, mesothelioma...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.